In support of this notion, loss of FOXA1 is reported to be vital in epithelial-mesenchymal transition (EMT) in multiple cell types (Song et al. 2010, Huang et al. 2016, Wang et al. 2016) including prostate cancer (Jin et al. 2013). This evidence concerns the gene FOXA1 and prostate cancer.